2. Academic Validation
  3. Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors

Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors

  • J Med Chem. 2008 Nov 13;51(21):6642-5. doi: 10.1021/jm800986w.
Yangbo Feng 1,  Yan Yin,  Amiee Weiser,  Evelyn Griffin,  Michael D Cameron,  Li Lin,  Claudia Ruiz,  Stephan C Schürer,  Toshihiro Inoue,  P Vasanth Rao,  Thomas Schröter,  Philip Lograsso
Affiliations

Affiliation

  • 1 Department of Molecular Therapeutics, and Translational Research Institute, The Scripps Research Institute, Florida, 5353 Parkside Drive, Jupiter, Florida 33458, USA.
PMID: 18834107 DOI: 10.1021/jm800986w
Abstract

The identification of a new class of potent and selective ROCK-II inhibitors is presented. Compound 5 (SR-3677) had an IC 50 of approximately 3 nM in Enzyme and cell based assays and had an off-target hit rate of 1.4% against 353 kinases, and inhibited only 3 out of 70 nonkinase enzymes and receptors. Pharmacology studies showed that 5 was efficacious in both, increasing ex vivo aqueous humor outflow in porcine eyes and inhibiting Myosin light chain phosphorylation.

Figures
Products